Astrazeneca Share News (AZN)

LONDON MARKET CLOSE: BoE chief lifts FTSE 100; Disney up in New York

(Alliance News) - London's FTSE 100 hit another record high on Thursday as largely soothing words from the Bank of England governor lifted the mood, while equities in New York joined in on the action, with Walt Disney a star performer.

AstraZeneca goes for growth with new drugs as COVID sales wane

Sees profit growth in 2023

*

LONDON MARKET MIDDAY: Standard Chartered takeover talks lift FTSE 100

(Alliance News) - Stock prices in London were largely higher at midday on Thursday, thanks to a strong set of results from drug maker AstraZeneca and renewed takeover talks for lender Standard Chartered.

Lessons from the 1970s

STOXX 600 up 1.1%

*

The German inflation brain teaser

STOXX 600 up 0.8%

*

STOXX: Action-packed start

STOXX 600 up 0.8%

*

LONDON MARKET OPEN: BAT falls on sales miss; Entain hit by MGM remark

(Alliance News) - Stock prices in London opened higher on Thursday, as investors digested a mixed set of UK company earnings.

TOP NEWS: AstraZeneca swings to profit as Alexion adds to 2022 revenue

(Alliance News) - AstraZeneca PLC on Thursday reported a swing to full-year profit and saw a double-digit revenue rise, despite a weaker fourth quarter.

LONDON BRIEFING: AstraZeneca swings to profit; Unilever volumes fall

(Alliance News) - Stocks in London were called to open higher on Thursday, as investors in Europe kept their cool, despite hawkish US central bankers and a weak finish on Wall Street.

European shares set for positive start

Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at

AstraZeneca FY core EPS in line

(Sharecast News) - Pharma giant AstraZeneca reported full-year earnings in line with expectations and said it expected 2023 core profits to increase by high-single to low-double digits.

UK's FTSE 100 hits record high on BP boost, less-hawkish Powell

BP touches 3-year high

*

CORRECT: EU approves AstraZeneca's Forxiga for chronic heart failure

(Corrects share price information.)

TOP NEWS: EU approves AstraZeneca's Forxiga for chronic heart failure

(Alliance News) - AstraZeneca PLC on Tuesday announced that the EU has approved its drug Forxiga for the treatment of symptomatic chronic heart failure.

UK stocks slip as rate hike worries grip investors

Global sentiment dented by worries over higher interest rates

*